Infectious Disease
The vaccine uses a harmless virus to deliver a MERS coronavirus protein into cells to generate an immune response
| 2 min read
OXGENE and The Native Antigen Company are developing an improved, scalable approach to SARS-CoV-2 antigen manufacture
| 2 min read
To speed the pace of research, Data Expedition, Inc. offers software at no charge to move datasets quickly and reliably between hospitals, labs, and research institutes
| 2 min read
Researchers were able to act quickly because they had already laid the groundwork during earlier coronavirus epidemics
| 3 min read
Testing available to hospitals and clinics or to patients with provider authorization code
| 2 min read
Care Access Research to lead clinical trial of breakthrough coronavirus test
| 2 min read
Team aims to build an advanced artificial intelligence engine that can support and empower the research and innovation sectors globally
| 2 min read
A University of Miami research team is hoping to document how cannabis users are faring during the height of the coronavirus pandemic in the US
| 2 min read
In engineered human tissue, the drug effectively blocked the cellular door SARS-CoV-2 uses to infect its hosts
| 3 min read
Thousands of samples can be analyzed daily
| 3 min read
